FEMSelect is a Woman-Led Company

As co-CEOs of FEMSelect, Debbie and Renee both have a deep understanding of the debilitating symptoms and emotional strains caused by prolapse. Over their careers, both have been committed to women’s health and are leading together to develop innovative and safe solutions for women.

Debbie Garner

Co-CEO

Debbie has 20 years of experience in commercialization leadership roles. She has launched and built the market for innovative women’s health care products with Eli Lilly and Co. and iMDsoft in numerous international markets. Debbie holds an MBA from the Wharton School of Business of the University of Pennsylvania and a BA from Harvard College.

Renee Selman

Co-CEO

Renee brings 25+ years of pharma, medical device & digital health senior management experience. She is former Global President with Ethicon, Women’s Health & Urology where she led an organizational turnaround growing sales 45%, improving net income and growing key emerging markets by more than 20% through market development.

Prof. Menahem Neuman

Founder & Medical Director

Menahem is currently Head of Urogynecology, Galilee Medical Center and Bar-Ilan University. Prior to this, he was Ethicon Women’s Health & Urology PFR global trainer and Pelvic Floor Innovation Committee Member.

Michael Adomiak

Market Development Director

Michael brings 15 years of field experience in the arena of Female Pelvic Reconstructive Surgery, working for large device companies Johnson & Johnson and Coloplast. He has built a national network of relationships with key opinion leaders in the field. He has also led physician adoption of new surgical innovation with several products for the treatment of female pelvic floor disorders. His passion is effective surgeon education and skill development to optimize product performance.

Boaz Harari

Founder VP Research & Development

Boaz has over 20 years of experience in the medical device field. Former CTO of VibeMedic Ltd. and Niti Surgical Solutions Ltd. He is an experienced engineer who has developed numerous clinical devices from concept to market.

Sherwyn Davidson

VP Quality and Regulatory Affairs

Sherwyn is an experienced medical device Quality Management and Regulatory professional. He has over 20 years of experience interacting with regulatory authorities and establishing and maintaining a Quality Management System with more than 10 years as Senior Project Manager at Medicsense Ltd., a leading Israeli consulting firm. Sherwyn holds a B.Sc. in Industrial Engineering from Ben-Gurion University.

Enplace® Development Timeline

2012

POP Medical Solutions Ltd. founded.

2014

First in Woman Clinical Study begins.

2016

EnPlace receives 510(k) clearance.

2018

EnPlace Post-Marketing Clinical Study Kickoff.
CE Mark obtained.

2019

Rebranded to EnPlace™ to reflect physician & patient perception. Clinical Data accepted for society presentations.

2020

EnPlace Commercial Launch.

Pin It on Pinterest